The Facts on the Gardasil Vaccine
The following are the major points from a report on the Gardasil vaccine, the link for which can be found at the bottom of this post.
The efficacy of Gardasil in preventing cervical cancer has not been demonstrated and the marketing campaign has been misleading.
The efficacy of Gardasil remains unsubstantiated since the vaccine hasn’t been adequately tested on the primary age group
Currently, in the US, the death rate from cervical cancer is lower than the rate of reported serious adverse events, including death, from Gardasil
Cervical cancer is a rare disease in developed countries which invalidates the recommendations for universal immunization with any HPV vaccine
Most HPV infections are benign and resolve spontaneously without causing cervical cancer
Gardasil clinical trials, all conducted by the manufacturer, were inadequate and methodologically flawed
Gardasil contains sodium-borate (70 μg/mL) which, according to a 2005 listing at The National Library of Medicine (NLM) of the National Institutes of Health, is no longer commonly used in medicinal products due to its high toxicity 56. Symptoms of sodium borate poisoning include: collapse, seizures, coma, death, muscular spasms, dullness, lethargy, circulatory depression, central nervous system depression, kidney damage, nausea, vomiting, diarrhea, fever, low blood pressure
Gardasil contains polysorbate 80 (100 μg/mL), a non-ionic detergent suspected to cause sudden unconsciousness, arrythmias, chest pain, nausea, headaches, vomiting and diarrhea, dizziness, confusion, breathing irregularities, diminished resistance to infection and increased incidence of upper respiratory tract infections, in users of Darbepoetin Alfa, a drug which is also administered by injection
Professional medical association (PMAs) including the American College of Obstetricians and Gynecologists, the American Society for Colposcopy and Cervical Pathology, the Society for Gynecologic Oncologists, and the American College Health Association received funding from Merck in educational campaigns to promote vaccine use
SUMMARY: Clinical trials on Gardasil have been largely inadequate, the efficacy of the vaccine in preventing cervical cancer has not been demonstrated, the benefits of vaccination have been exaggerated and safety concerns downplayed, thus preventing parents from making informed decisions for their children. Routine immunization against cervical cancer with Gardasil is not supported by the current data. The benefit of vaccination is uncertain and the risks of serious adverse effects are substantial.
Link to report for extensive, referenced information on above points
If you have any questions, suggestions, requests, or proposals, you may either send us an email at email@example.com or leave a comment at the bottom of this webpage.